Engineers Gate Manager LP Satsuma Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$3.78 - $5.32 $42,611 - $59,972	-11,273 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.15 - $6.24 $30,104 - $45,264	-7,254 Reduced 39.15%	11,273 $51,000
Q3 2021 Nov 15, 2021	BUY	$4.54 - $7.17 $4,172 - $6,589	919 Added 5.22%	18,527 $86,000
Q2 2021 Aug 16, 2021	BUY	$4.8 - $7.25 $1,526 - $2,305	318 Added 1.84%	17,608 $124,000
Q1 2021 May 17, 2021	BUY	$4.57 - $7.18 $16,506 - $25,934	3,612 Added 26.41%	17,290 $102,000
Q4 2020 Feb 16, 2021	SELL	$3.56 - $5.09 $37,458 - $53,556	-10,522 Reduced 43.48%	13,678 $63,000
Q3 2020 Nov 16, 2020	BUY	$3.85 - $28.47 $93,170 - $688,974	24,200 New	24,200 $94,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.